Ecomic Co., Ltd (TYO:3802)

Orchard Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,350	1,491	1,049	824	690
Cash & Short-Term Investments	1,350	1,491	1,049	824	690
Cash Growth	-9.46%	42.13%	27.31%	19.42%	14.43%
Receivables	174	173	166	111	103
Inventory	1	3	10	-	-
Other Current Assets	58	55	46	37	33
Total Current Assets	1,583	1,722	1,271	972	826
Property, Plant & Equipment	78	61	91	79	50
Long-Term Investments	72	89	72	68	47
Goodwill	32	48	63	-	-
Other Intangible Assets	190	183	211	221	180
Long-Term Deferred Tax Assets	12	5	8	4	9
Other Long-Term Assets	2	2	1	2	1
Total Assets	1,969	2,110	1,717	1,346	1,113
Accounts Payable	24	24	22	18	18
Accrued Expenses	-	-	114	83	-
Current Portion of Long-Term Debt	-	23	33	-	-
Current Income Taxes Payable	36	24	49	67	18
Other Current Liabilities	83	103	59	35	65
Total Current Liabilities	143	174	277	203	101
Long-Term Debt	-	91	132	-	-
Long-Term Deferred Tax Liabilities	25	25	5	-	-
Other Long-Term Liabilities	1	1	5	-	1
Total Liabilities	169	291	419	203	102
Common Stock	564	564	364	360	354
Additional Paid-In Capital	399	399	199	195	189
Retained Earnings	786	799	703	555	464
Comprehensive Income & Other	51	57	32	33	4
Shareholders' Equity	1,800	1,819	1,298	1,143	1,011
Total Liabilities & Equity	1,969	2,110	1,717	1,346	1,113
Total Debt	-	114	165	-	-
Net Cash (Debt)	1,350	1,377	884	824	690
Net Cash Growth	-1.96%	55.77%	7.28%	19.42%	14.43%
Net Cash Per Share	287.65	355.93	232.07	217.44	184.83
Filing Date Shares Outstanding	4.69	4.69	3.82	3.8	3.77
Total Common Shares Outstanding	4.69	4.69	3.82	3.8	3.77
Working Capital	1,440	1,548	994	769	725
Book Value Per Share	383.54	387.59	340.19	300.98	268.03
Tangible Book Value	1,578	1,588	1,024	922	831
Tangible Book Value Per Share	336.24	338.37	268.38	242.79	220.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.